News

Heart1h
Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease
Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...
Heart6d
Severity of mobility limitation and adverse outcomes in heart failure
Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between ...
Opinion
Heart5dOpinion
It is time to treat cannabis as an important risk factor for cardiovascular disease
Legalisation of medical and recreational cannabis commerce is spreading around the world, associated with increased use1 and falling perception of the risk.2 Frequent cannabis use has increased in ...
Heart5d
Impact of air pollution and multimorbidity on the risk of incident atrial fibrillation
Background Emerging evidence suggests associations between air pollution, multimorbidity, and atrial fibrillation (AF), but their interplay remains unclear. We evaluated these relationships in a ...
BMJ4d
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions
Correspondence to Dr Radoslaw Marek Debiec, Cardiovascular Sciences, University of Leicester College of Medicine Biological Sciences and Psychology, Leicester LE3 9QP, UK; rmd24{at}le.ac.uk Aim The ...
BMJ7d
Insights from Norway on implementing the 2024 European Society of Cardiology Guidelines for elevated blood pressure and hypertension
The 2024 European Society of Cardiology (ESC) Guidelines on elevated blood pressure (BP) and hypertension reflect a shift from binary thresholds towards a risk-based management approach that aims to ...
BMJ10d
Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis
5 Department of Cardiothoracic Surgery, National Heart Centre Singapore, Singapore 6 Department of Cardiology, National University Heart Centre, Singapore Objective To investigate the prognostic ...
BMJ4d
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease
Objectives (1) Describe how the risk of major adverse cardiovascular events (MACE) in individuals with chronic myeloid leukaemia (CML) has evolved; (2) evaluate the risk of MACE associated with the ...
BMJ13d
When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation
Objectives This updated hierarchical Bayesian meta-analysis aims to integrate the latest randomised controlled trials (RCTs) on the use of cerebral embolic protection (CEP) in transcatheter aortic ...
BMJ8d
Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ13d
Reshaping the paradigm: towards holistic cardiovascular risk assessment in older adults
In his song ‘Envelhecer’ (‘Aging’), Arnaldo Antunes states that “the most modern thing there is in this life is to grow old”.1 In this piece, he reframes aging not only as an inevitable biological ...
BMJ4d
What is the normal composition of pericardial fluid?
5 Dean for Medical Professions, College of Law and Business, Ramat Gan, Israel, Sackler Faculty of Medicine, Tel Aviv University, Mayanei Hayeshua, Medical Center, Bnei Brak, Israel Objective ...